036220 — Osang Healthcare Co Balance Sheet
0.000.00%
- KR₩187bn
- KR₩179bn
- KR₩80bn
- 26
- 45
- 24
- 19
Annual balance sheet for Osang Healthcare Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 93,129 | 47,106 | 61,140 | 142,547 | 9,363 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 49,672 | 45,550 | 46,460 | 26,057 | 28,115 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 186,139 | 115,012 | 158,410 | 185,386 | 62,615 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 36,851 | 41,915 | 48,666 | 61,581 | 64,462 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 244,716 | 189,375 | 249,184 | 320,547 | 295,000 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 46,626 | 10,627 | 49,151 | 26,879 | 8,360 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 46,626 | 10,918 | 49,328 | 27,520 | 9,252 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 198,090 | 178,457 | 199,855 | 293,027 | 285,748 |
Total Liabilities & Shareholders' Equity | 244,716 | 189,375 | 249,184 | 320,547 | 295,000 |
Total Common Shares Outstanding |